Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Dr. Frei awarded 2018 Educator of the Year

May 7, 2018
Dr. Christopher R. Frei was declared the College of Pharmacy’s 2018 Educator of the Year Award winner. The announcement was one of several teaching awards to college faculty announced recently at the student-sponsored awards ceremony.